The relation of anthropometric measures, diabetes, hypertension and hyperlipidemia with benign prostatic hyperplasia (BPH) risk was investigated. DESIGN: Hospital-based case-control study. SUBJECTS: Cases were 1369 men with histologically confirmed BPH, and controls were 1451 men below 75 y, admitted to hospital for acute non-neoplastic diseases. MEASUREMENTS: Using a structured questionnaire, trained interviewers collected information on self-reported height and weight, and measured waist and hip circumference of patients. The odds ratios (OR) and 95% confidence intervals (CI) were estimated using unconditional multiple logistic regression models. RESULTS: Compared to the corresponding lowest quartile, the OR for the highest one were 0.76 (95% CI 0.59-0.98) for body weight, 0.71 (95% CI 0.54-0.94) for waist-to-hip ratio and 0.87 (95% CI 0.70-1.09) for body mass index (BMI, kg/m 2 ). Compared to a lowest lifelong BMI o20.7 kg/m 2 , the OR was 1.56 (95% CI 1.25-1.95) for a lowest lifelong BMI Z23.7 kg/m 2 . The OR was 0.74 (95% CI 0.60-0.93) for a lifelong increase of BMI Z6.1 kg/m 2 , compared to o1.6 kg/m 2 . No association emerged for history of diabetes, hypertension and hyperlipidemia. CONCLUSIONS: Overweight was modestly, inversely related to BPH. The hypothesis of reduced testosterone levels in obese individuals may explain the different BPH risk and need to be tested.
Introduction
A potential relation between benign prostatic hyperplasia (BPH) and anthropometric measures, obesity and selected diseases has been investigated, but the results are unclear. 1 Among prospective studies considering the relation between body weight and BPH risk, the prospective Veterans Administration Normative Aging Study found a direct association; 2 the Northern California Kaiser Permanente Medical Care Program found an inverse association; 3 a cohort of 929 men from California; 4 
and the population-based Massachussetts
Male Aging Study cohort 5 found no association; 4, 5 and the Health Professionals Follow-up Study found a direct association with abdominal obesity, but not with body mass index (BMI, kg/m 2 ). 6 Among case-control studies, a Greek one found no association between BMI and BPH, 7 and a Chinese one found no relation with BMI, but a direct association with waist-to-hip ratio. 8 Two other studies found direct associations. 9 , 10 An American case-control study on Black men found that BMI was directly associated with prostate volume, 9 and a Swedish study reported that men with fastgrowing BPH were more obese. 10 A role of diabetes in the etiology of BPH has been suggested based on uncontrolled clinical observations and on the high prevalence of the disease among men presenting for prostatectomy. Moreover, men with severe type-2 diabetes have lower androgen levels, 11 and diabetes is often associated with obesity and with several hormonal alterations possibly related to the risk of BPH. 1, 12 considered the role of hypertension on the risk of BPH and found no relation. However, in a Swedish study men with fast-growing BPH had higher prevalence of hypertension.
10
No association with serum cholesterol levels was found in the prospective Veterans Administration Normative Aging Study.
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Given the high incidence of BPH and the rising global epidemic of obesity and consequently of diabetes, hypertension and hyperlipidemia, we analyzed these relations in a large case-control study conducted in Italy, including information on several relevant covariates.
Subjects and methods
The data were derived from a case-control study on BPH, conducted between 1991 and 2002 in four Italian areas: the provinces of Pordenone and Gorizia (North-eastern Italy), greater Milan (northern Italy), the province of Latina (central Italy) and the urban area of Naples (southern Italy). All interviews were conducted in hospital by trained interviewers using a structured questionnaire. Less than 5% of cases and controls approached refused interview, and the response rates did not vary across hospitals and geographic areas.
Cases were 1369 men (median age 66, range 46-74 y) with histologically confirmed BPH, admitted to the major teaching and general hospitals in the areas under surveillance. Controls were 1451 men (median age 63, range 46-74 y), residing in the same geographical areas and admitted to the same network of hospitals of cases for a wide spectrum of acute conditions unrelated to known or potential risk factors for BPH. Among controls, 21% had traumatic conditions, 32% nontraumatic orthopedic disorders, 17% acute surgical conditions and 29% miscellaneous other illnesses (such as eye, ear, nose, throat and dental disorders).
The structured questionnaire included information on sociodemographic factors, anthropometric variables, general lifestyle habits, such as smoking, alcohol and coffee consumption, a validated 78-item food frequency section, 13 and physical activity at work (five categories: very heavy, heavy, average, standing, mainly sitting) and at leisure time (hours/week of sport or activities such as walking, cycling, gardening).
14 Information on family history of cancer was also collected.
Subjects were asked to report their height and habitual weight 1 y before the interview, reported body size at 12 y of age (ie thinner, similar, heavier than peers), weight at 30 and 50 y of age, and highest and lowest weights in adult life (420 y old). Waist and hip circumferences were measured by interviewers. In 37% of BPH cases and 24% of controls, these measures were missing. To estimate body size and build, we computed waist-to-hip ratio and BMI (weight/height 2 , kg/m 2 ). Information on personal history of selected diseases, including diabetes mellitus, history of hypertension and hyperlipidemia, were self-reported and included age at first diagnosis.
Data analysis
Odds ratios (OR) and the corresponding 95% confidence intervals (CI) were estimated using unconditional multiple logistic regression models 15 including terms for: quinquennia of age (six categories), center, education (o7/7-11/ Z12 y) and physical activity (very active/moderately active/ inactive at work at age 30-39 y). Additional terms for family history of prostate cancer (no/yes), calorie intake (tertiles), smoking (never/ex/current smokers of o15/15-24/Z25 cigarettes/ day) and alcohol drinking habits (never/ex/current drinkers of o14/14-20/21-34/Z35 drinks/day) did not materially modify any risk estimate and, therefore, were not included in the final model. Table 1 shows the distribution of cases and controls by age, education and physical activity. Cases were older than controls, more educated and reported less frequent physical activity at work. Table 2 shows the relation between selected medical conditions and the risk of BPH. The multivariate OR for BPH was 1.19 for history of diabetes, 0.94 for hypertension and 1.06 for hyperlipidemia. Table 3 shows the distribution of BPH cases and controls, with the corresponding ORs according to various anthropometric measures. Compared to subjects less than 169 cm in height, the OR for the highest height category and the trend in risk were not significant after adjustment for weight (OR 0.89). However, without adjustment for weight, the ORs were 1.09 (95% CI 0. Table 4 . No association was found for reported body size at 12 y, with an ORs of 0.92 for heavier boys compared to thinner peers. Compared to the lowest quartile of BMI at age 30 and 50 y, the ORs for higher BMI were generally above unity, although the trend in risk was not significant. At age 30 y, the OR was 1.28 for the highest quartile of BMI compared to the lowest one, and at age 50 y, the OR was 0.99 for the highest quartile of BMI compared to the lowest one. The OR for the highest lifelong quartile of BMI compared to the lowest category was 0.79. 
Results

Discussion
This study shows an inverse association of the risk of BPH with obesity 1 y before diagnosis and with a lifelong increase in BMI from the lowest during life to BMI 1 y before diagnosis, while a direct association emerged for BMI at age 30 y. No association was found for diabetes, history of hypertension and hyperlipidemia, in agreement with most epidemiological evidence. 2, 3, 5, 7, 10 A potential weakness of this study is the lack of a precise definition of BPH, as there is no unique clinical definition of this disease. 1 Although we excluded from the control group all subjects who reported a diagnosis of BPH or prostate cancer, a potential source of bias could derive from undetected cases of BPH in the control group. 16 During the period of our study, prostate-specific antigen (PSA) testing
was not yet a common screening practice in Italy. However, strict allowance was made for education, since a higher prevalence of PSA testing among more educated men is likely.
The information on personal medical conditions provided by hospital controls through an interviewer-administered questionnaire is satisfactorily reproducible for the purposes of epidemiological inference (k of agreement 0.85 for diabetes) and the interview setting does not substantially influence the recall of this information. 17 In our study, anthropometric measurements were self-reported; however, although self-reported height tend to be overestimated and weight underestimated, [18] [19] [20] [21] there is no reason why selfreported weight and height measures should be differently biased between cases and controls. 22 Thus, any systematic underestimation of BMI should not lead to major biases in risk estimates. Body measurements have been generally well correlated with corresponding past measurements even in older persons. 23 Other possible sources of bias should be limited, since cases and controls were drawn from the same catchment areas and participation was almost complete, and allowance for several potential confounding factors did not notably modify the risk estimates. The results were consistent when comparison was made with different diagnostic categories of controls. Thus, when controls with traumatic conditions were excluded from the analyses, the OR for an increase in BMI (from the lowest during life to BMI 1 y before diagnosis) of 6.1 kg/m 2 or more was not materially different from that reported for the whole group of controls. The real association is further supported by the lack of significant association between BMI and prostate cancer observed in a companion study. 24 Obesity has effects on many hormones, including an increase of estrogen and decrease of testosterone levels, 1 due to aromatization of androgens to estrogens in the adipose tissue. 25 Androgens are involved in the development and maintenance of BPH, as supported by androgen receptor expression in prostate epithelium, 26, 27 and by the observation of high testosterone levels in men with prostate cancer in several, although not all studies. 28 Androgen receptor gene polymorphisms (and particularly a CAG repeat length of o21 and a CGN repeat length o16) was also associated with the risk of BPH in a study from Olmsted County, MN, USA. 29 Some studies reported that a reduction occurs in the hyperplastic prostate mass, primarily of the epithelium, and Pharmacological inhibition of dihydrotestosterone, a testosterone metabolite present in the prostate, is associated with a reduction in prostate size, urinary symptoms and surgery for BPH. 37, 38 In the Health Professional Follow-up Study, men who had surgery of BPH had lower androstanediol glucoronide levels (a precursor of dihydrotestosterone) and higher estradiol levels. 39 Thus, an inverse relation of recent obesity with BPH risk is biologically plausible. Recent overweight and obesity are therefore important, as indicated by the inverse association with waist-to-hip ratio at diagnosis, with BMI 1 y before diagnosis and with increases in body weight during life, rather than with obesity earlier in life (ie at age 30 and 50 y). Our data confirm that diabetes is unrelated to BPH. 2, 5, 7 Along this line, Mantzoros et al 40 showed no relation between IGF-1 and BPH risk, but the issue is not clear.
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Likewise, hypertension was unrelated to BPH and chronic retention of urine may be a cause rather than an effect of hypertension.
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